Kala Pharmaceuticals Announces Availability of EYSUVIS™ for the Treatment of Dry Eye Disease and Provides Update on Development Pipeline by Seini Moimoi | Jan 7, 2021 | Portfolio News
Vaxcyte Announces Publication of Preclinical Proof-of-Concept Data Supporting Potential of VAX-A1, a Novel Conjugate Vaccine Designed to Prevent Group A Strep Infections by Seini Moimoi | Jan 6, 2021 | Portfolio News
Inozyme Pharma Announces Authorization to Proceed in U.S. and U.K. with Phase 1/2 Clinical Trial of INZ-701 for the Treatment of ENPP1 Deficiency by Seini Moimoi | Jan 4, 2021 | Portfolio News
Checkmate Pharmaceuticals Announces Key Additions to Executive Management Team by Seini Moimoi | Jan 4, 2021 | Portfolio News
WelbeHealth Administers First Shipment of COVID-19 Vaccines to Most Vulnerable Seniors by Seini Moimoi | Dec 31, 2020 | Portfolio News
Orbus Therapeutics Receives U.S. Patent for Eflornithine Formulations by Seini Moimoi | Dec 23, 2020 | Portfolio News
